Sentinel Oncology is a fully integrated drug discovery company seeking to develop high quality drugs andidates for partnering with the pharmaceutical and biotechnology sectors. Their business model is collaborative and they partner with organisations who can maximise the value of our programmes.

Status Active
Website http://www.sentineloncology.com
Category Biotech
Modality Small Molecule
Therapautics Area
Headquaters Cambridge, UK
Partner Seattle Genetics Innovate UK
Investment Portfolio Pre-Fund Investment
Co-Investors Wellcome Trust Business Angels